CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival

CONCLUSIONS: Prevalence of CD3+ CD137+ TILs in digested OC specimens is associated with improved OS, while general TIL markers are not. CD137 has the potential to be a novel biomarker for survival in OC.PMID:38290413 | DOI:10.1016/j.ygyno.2024.01.029

Source: Gynecologic Oncology - January 30, 2024 Category: Cancer & Oncology Authors: Elizabeth A Tubridy Monika A Eiva Fang Liu Dalia K Omran Stefan Gysler Erica G Brown Allison G Roy Yuyan Zeng Jinhee Oh Quy Cao Sarah B Gitto Daniel J Powell Source Type: research